Risk factors for oral mucositis in children receiving hematopoietic cell transplantation for primary immunodeficiencies: A retrospective study

Pediatric Transplantation

Volumn 17, Issue 5, 2013, Pages 492-497

  Bardellini, E ^a   Schumacher, F ^b   Conti, G ^c   Porta, F ^b   Campus, G ^d   Majorana, A ^a,e  

^a UNIVERSITY OF BRESCIA   (Italy)

^b Laryngology Spedali Civili di Brescia   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSITY OF SASSARI   (Italy)

^e Dental Clinic   (Italy)

Author keywords

oral mucositis; primary immunodeficiencies; risk factors

Indexed keywords

ALEMTUZUMAB; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ETOPOSIDE; MELPHALAN; METHOTREXATE; THIOTEPA; THYMOCYTE ANTIBODY;

ARTICLE; CHILD; CHILDHOOD DISEASE; DISEASE DURATION; DISEASE SEVERITY; DONOR; ENGRAFTMENT; FEMALE; FOOD INTAKE; GENDER; GRAFT VERSUS HOST REACTION; GROUPS BY AGE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH RISK PATIENT; HUMAN; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; ORAL MUCOSITIS; PRESCHOOL CHILD; RATING SCALE; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; T LYMPHOCYTE;

ORAL MUCOSITIS; PRIMARY IMMUNODEFICIENCIES; RISK FACTORS;

CHILD; CHILD, PRESCHOOL; EATING; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; INFANT; MALE; RETROSPECTIVE STUDIES; RISK FACTORS; STOMATITIS; TRANSPLANTATION CONDITIONING;

EID: 84879882328     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/petr.12094     Document Type: Article

References (23)

1. Bellm LA, Epstein JB, Rose-Ped A, Martin PJ, Fuchs HJ,. Patient reports of complication of bone marrow transplantation. Support Care Cancer 2000: 8: 33-39.
2. Sonis ST, Oster G, Fuchs H, et al. Oral mucositis and the clinical and economic outcomes of hematopoietic stem cell transplantation. J Clin Oncol 2001: 19: 2201-2205.
3. Silverman S,. Diagnosis and management of oral mucositis. J Support Oncol 2007: 5: 13-21.
4. Sonis ST,. Oral mucositis. Anticancer Drugs 2011: 22: 607-612.
5. Sonis ST,. The pathobiology of mucositis. Nat Rev Cancer 2004: 4: 277-284.
6. Sonis ST,. Pathobiology of oral mucositis: Novel insights and opportunities. J Support Oncol 2007: 5: 3-11.
7. Sonis ST,. Mucositis as a biological process: A new hypothesis for the development of chemotherapy-induced stomatotoxicity. Oral Oncol 1998: 34: 39-43.
8. Reucher TJ, Sodeifi A, Scrivani SJ, Kaban LB, Sonis ST,. The impact of mucositis on a haemolytic streptococcal infection in patients undergoing autologous bone marrow transplantation for hematologic malignancies. Cancer 1998: 82: 2275-2281.
9. Filipovich A,. Hematopoietic cell transplantation for correction of primary immunodeficiencies. Bone Marrow Transplant 2008: 42: S49-S52.
10. World Health Organization. WHO Handbook for Reporting Results of Cancer Treatment. Geneva, Switzerland: World Health Organization, 1979: 15-22.
11. Farrington M, Cullen L, Dawson C,. Assessment of oral mucositis in adult and pediatric oncology patients: An evidence-based approach. ORL Head Neck Nurs 2010: 28: 8-15.
12. Vagliano L, Feraut C, Gobetto G, et al. Incidence and severity of oral mucositis in patients undergoing haematopoietic SCT-results of a multicentre study. Bone Marrow Transplant 2011: 46: 727-732.
13. Ethier MC, Regier DA, Tomlinson D, et al. Perspectives toward oral mucositis prevention from parents and health care professionals in pediatric cancer. Support Care Cancer 2012: 20: 1771-1777.
14. Tomlinson D, Judd P, Hendershot E, Maloney A, Sung L,. Measurement of oral mucositis in children: A review of the literature. Support Care Cancer 2007: 15: 1251-1258.
15. Tomlinson D, Judd P, Hendershot E, Maloney A, Sung L,. Establishing literature-based items for an oral mucositis assessment tool in children. J Pediatr Oncol Nurs 2008: 25: 139-147.
16. Sung L, Tomlinson GA, Greenberg ML, et al. Validation of the oral mucositis assessment scale in pediatric cancer. Pediatr Blood Cancer 2007: 49: 149-153.
17. Robien K, Schubert MM, Bruemmer B, Lloid ME, Potter JD, Ulrich CM,. Predictors of oral mucositis in patients receiving hematopoietic cell transplants for chronic myelogenous leukemia. J Clin Oncol 2004: 22: 1268-1275.
18. Kashiwazaki H, Matsushita T, Sugita J, et al. A comparison of oral mucositis in allogeneic hematopoietic stem cell transplantation between conventional and reduced-intensity regimens. Support Care Cancer 2012: 20: 933-939.
19. Molina B, Alonso L, Gonzalez-Vicent M, et al. High-dose busulfan and melphalan as conditioning regimen for autologous peripheral blood progenitor cell transplantation in high-risk neuroblastoma patients. Pediatr Hematol Oncol 2011: 28: 115-123.
20. Wardley AM, Jayson GC, Swindell R, et al. Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoietic progenitor rescue. Br J Haematol 2000: 110: 292-299.
21. Antin JH, Kim HT, Cutler C, et al. Sirolimus, tacrolimus, and low-dose methotrexate for graft-versus-host disease prophylaxis in mismatched related donor or unrelated donor transplantation. Blood 2003: 102: 1601-1605.
22. Sacks GS, Ayinala S, Donelson SS, et al. Utilization of parental nutrition in patients receiving peripheral blood stem cell transplantation. J Miss State Med Assoc 2000: 41: 579-584.
23. Muscaritoli M, Grieco G, Capria S, Iori A, Rossi F,. Nutritional and metabolic support in patients undergoing bone marrow transplantation. Am J Clin Nutr 2002: 75: 183-190.